Glossary

The time after treatment ends when participants are monitored for long-term effects.

The maximum number of participants allowed in a clinical trial.

Grouping participants based on specific characteristics before randomization.

A group of participants sharing a common characteristic or condition in a trial.

The application of statistics to analyze biological and clinical trial data.

Assessments or tests used to identify eligible participants for a trial.

The length of time a clinical trial is conducted.

A measure of a participant�s overall well-being during a study.

Initial measurements taken at the start of a clinical trial to compare with later results.

Any unwanted effect caused by a drug or intervention.

A document summarizing information about an investigational product for researchers.

The first visit to determine if a person meets trial eligibility criteria.

The study of the effects a drug has on the body.

The study of how a drug is absorbed, distributed, metabolized, and eliminated in the body.